Liu, Huayang
Golji, Javad
Brodeur, Lauren K.
Chung, Franklin S.
Chen, Julie T.
deBeaumont, Rosalie S.
Bullock, Caroline P.
Jones, Michael D.
Kerr, Grainne
Li, Li
Rakiec, Daniel P.
Schlabach, Michael R.
Sovath, Sosathya
Growney, Joseph D.
Pagliarini, Raymond A.
Ruddy, David A.
MacIsaac, Kenzie D.
Korn, Joshua M.
McDonald, E. Robert III http://orcid.org/0000-0001-8165-9381
Article History
Received: 19 January 2018
Accepted: 13 November 2018
First Online: 17 December 2018
Competing interests
: All authors performed the work herein as employees of the Novartis Institutes for Biomedical Research, Inc. NIBR employees are also Novartis stockholders. R.A.P. is an employee and equity holder of Celsius Therapeutics. J.D.G. is a former employee of Novartis and is currently an employee of the Broad Institute of MIT and Harvard.